About: Penta marker test evaluates the risk of chromosomal abnormalities such as Edwards & Down s...Read more
Blood
Unlock special
discount on
this package
Login to Unlock 🔓
5 Test Parameters
Alpha Fetoprotein (AFP), Maternal Marker
1 PARAMETER INCLUDED
1 PARAMETER INCLUDED
Free Beta HCG
1 PARAMETER INCLUDED
1 PARAMETER INCLUDED
Inhibin A
1 PARAMETER INCLUDED
1 PARAMETER INCLUDED
Placental Growth Factor (PLGF)- Roche (SSDW)
1 PARAMETER INCLUDED
1 PARAMETER INCLUDED
Pregnancy Associated Plasma Protein-A (PAPP-A)
1 PARAMETER INCLUDED
1 PARAMETER INCLUDED
The Penta Marker Test, also known as the maternal serum screening, is a prenatal blood test conducted during the first trimester of pregnancy. This test helps assess the risk of chromosomal abnormalities in the developing fetus, including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and open neural tube defects.
The test measures five specific markers in the mother's blood, providing valuable information about the health of the pregnancy. It is a non-invasive screening test that poses no risk to the mother or baby.
This screening test is recommended for all pregnant women, especially those who are 35 years or older, have a family history of genetic disorders, or have had abnormal ultrasound findings. Early detection allows parents and doctors to plan appropriate care and interventions.
No special preparation is required for the Penta Marker Test. However, it is important to inform your doctor about any medications you are taking. The test is typically performed between 11 to 14 weeks of pregnancy.
Results are usually available within a few days. Your doctor will interpret the results along with other factors such as your age, weight, and ultrasound findings to determine the overall risk assessment. A "screen positive" result does not mean the baby has a condition - it indicates that further diagnostic testing may be needed.